ANALYSIS-Torrid Moderna stock rally cools over booster shot doubts - Reuters

9:03am PDT - September 17th, 2021    s&p 500 - Reuters

Debate over the need for COVID-19 booster shots is clouding the outlook for Moderna Inc's high-flying shares after the U.S. biotechnology company's stock price soared as much as 360% this year, making it the best performer in the S&P 500.